Suzetrigine is the first nonopioid analgesic to earn FDA approval in 25 years. It curbs pain signals in a novel way. Excepteur sint occaecat cupidatat...
The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists Excepteur sint occaecat cupidatat non proident, sunt in culpa...
The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say Journavx is an important alternative because the power...